{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:05:16Z","timestamp":1778623516818,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ijcard.2009.03.120","type":"journal-article","created":{"date-parts":[[2009,4,29]],"date-time":"2009-04-29T05:29:33Z","timestamp":1240982973000},"page":"42-46","source":"Crossref","is-referenced-by-count":22,"title":["Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population"],"prefix":"10.1016","volume":"144","author":[{"given":"Pasi P.","family":"Karjalainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti-Pekka","family":"Annala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Ylitalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tero","family":"Vahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E. Juhani","family":"Airaksinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2009.03.120_bib1","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2009.03.120_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2009.03.120_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(04)16850-5","article-title":"A hierarchical bayesian meta-analysis of randomized clinical trials of drug-eluting stents","volume":"364","author":"Babapulle","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2009.03.120_bib4","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2009.03.120_bib5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"Mauri","year":"2007","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"10.1016\/j.ijcard.2009.03.120_bib6","first-page":"SC16","article-title":"Metal implants and surface reactions","volume":"27","author":"Steinemann","year":"1996","journal-title":"Injury"},{"key":"10.1016\/j.ijcard.2009.03.120_bib7","first-page":"835","article-title":"Comparison of endothelial cells grown on different stent materials","volume":"76","author":"Hung-I","year":"2006","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.ijcard.2009.03.120_bib8","first-page":"187","article-title":"Real world experience with the TITAN stent: a 9-month follow-up report from the Titan PORI registry","volume":"2","author":"Karjalainen","year":"2006","journal-title":"Eurointerv"},{"key":"10.1016\/j.ijcard.2009.03.120_bib9","first-page":"462","article-title":"Titanium and nitride oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population","volume":"18","author":"Karjalainen","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.ijcard.2009.03.120_bib10","first-page":"192","article-title":"The titanium-NO stent: results of a multicenter registry","volume":"2","author":"Mosseri","year":"2006","journal-title":"Eurointerv"},{"key":"10.1016\/j.ijcard.2009.03.120_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4244\/EIJV3I4A92","article-title":"Titan 2 bio-active stent (BAS) with titanium-NO","volume":"3","author":"Giraud-Sauveur","year":"2007","journal-title":"Eurointerv"},{"key":"10.1016\/j.ijcard.2009.03.120_bib12","first-page":"1843","article-title":"The microtubule-affecting drug paclitaxel has antiangiogenic activity","volume":"2","author":"Belotti","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijcard.2009.03.120_bib13","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1038\/sj.onc.1204487","article-title":"Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1\/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity","volume":"20","author":"Giannakakou","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ijcard.2009.03.120_bib14","series-title":"SPSS 11: introduction in modern data analysis","author":"Buehl","year":"2002"},{"key":"10.1016\/j.ijcard.2009.03.120_bib15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"Daemen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2009.03.120_bib16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.amjcard.2006.11.070","article-title":"Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-Search Registries)","volume":"99","author":"Daemen","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2009.03.120_bib17","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jacc.2008.07.006","article-title":"Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice","volume":"52","author":"Wenaweser","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2009.03.120_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2009.03.120_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents. Importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ijcard.2009.03.120_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.107.691451","article-title":"Drug-eluting stent update 2007: part II: unsettled issues","volume":"116","author":"Daemen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2009.03.120_bib21","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2009.03.120_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacc.2004.12.082","article-title":"Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies study (ARTS) randomized trial","volume":"46","author":"Serruys","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2009.03.120_bib23","first-page":"147","article-title":"Arterial revascularization therapies study part II \u2014 sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions","volume":"1","author":"Serruys","year":"2005","journal-title":"Eurointerv"},{"key":"10.1016\/j.ijcard.2009.03.120_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijcard.2008.11.048","article-title":"Ethical authorship and publishing","volume":"131","author":"Coats","year":"2009","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752730900415X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752730900415X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T01:58:57Z","timestamp":1545271137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752730900415X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S016752730900415X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2009.03.120","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}